Escitalopram Oxalate Solution
Product Images NDC 16571-769

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Escitalopram Oxalate (NDC 16571-769). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rising Pharma Holdings, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figuer1 (Escitalopram Fig1)

This is a drug label for Escitalopram Oral Solution USP with a concentration of 5mg per 5mL. It should be stored between 20-25°C (68° to 77°F) and dispensed in a tight container as described in the USP. The usual dosage is indicated in the package insert for full prescribing information. The label was issued in March 2021 and was made in India but distributed by Rising Pharmaceuticals in East Brunswick, NJ. It also includes a warning to keep the drug out of the reach of children and a Pharmacist Dispense With Medication Guide.*

FDA Label Image

Escitalopram Fig2

The text is a description of the medication "Escitalopram Oral Solution USP" with details on its contents, dosage, and storage instructions. The medication is distributed by Rising Pharma Holdings, Inc. and is available in 20mL and 240mL containers. The description includes a cautionary instruction to keep the drug out of the reach of children and to store it at a specific temperature as described in the USP. The code "TS/DRUGS/19/1993" is also included.*

FDA Label Image

Chemical Structure (Escitalopram Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.